TABLE OF CONTENTS
Volume 31, Issue 5 (March (1) 2003)
Post-transplant Complications |
Reduced Intensity Conditioning Transplants |
Stem Cell Mobilisation |
Osteosarcoma |
Murine Studies |
Chimerism |
Case Reports |
Correspondence |
Book Review
Mini Review
The whys and hows of hematopoietic progenitor and stem cell mobilization FREE
A Kessinger and J G Sharp
Bone Marrow Transplant 31: 319-329; doi:10.1038/sj.bmt.1703837
Post-transplant Complications
Total energy expenditure and body composition changes following peripheral blood stem cell transplantation and participation in an exercise programme FREE
S Hayes, P S W Davies, T Parker and J Bashford
Bone Marrow Transplant 31: 331-338; doi:10.1038/sj.bmt.1703867
Reduced Intensity Conditioning Transplants
Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved FREE
G Massenkeil, M Nagy, M Lawang, O Rosen, I Genvresse, G Geserick, B Dörken and R Arnold
Bone Marrow Transplant 31: 339-345; doi:10.1038/sj.bmt.1703859
Stem Cell Mobilisation
Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma FREE
E Jantunen, M Putkonen, T Nousiainen, T-T Pelliniemi, E Mahlamäki and K Remes
Bone Marrow Transplant 31: 347-351; doi:10.1038/sj.bmt.1703840
Osteosarcoma
Osteosarcoma after allogeneic bone marrow transplantation. A report of four cases from the Cooperative Osteosarcoma Study Group (COSS) FREE
S S Bielack, J S Rerin, R Dickerhoff, D Dilloo, B Kremens, A von Stackelberg, J Vormoor and H Jürgens for the Cooperative German–Austrian–Swiss Osteosarcoma Study Group COSS
Bone Marrow Transplant 31: 353-359; doi:10.1038/sj.bmt.1703864
Murine Studies
Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice FREE
S N Robinson, J M Chavez, V M Pisarev, R L Mosley, G J Rosenthal, J M Blonder and J E Talmadge
Bone Marrow Transplant 31: 361-369; doi:10.1038/sj.bmt.1703816
Stem Cell Mobilisation
Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim FREE
L B To, J Bashford, S Durrant, J MacMillan, A P Schwarer, H M Prince, J Gibson, I Lewis, B Swart, J Marty, T Rawling, L Ashman, S Charles and B Cohen
Bone Marrow Transplant 31: 371-378; doi:10.1038/sj.bmt.1703860
Post-transplant Complications
Polyoma viruria following T-cell-depleted allogeneic transplants using Campath-1H: incidence and outcome in relation to graft manipulation, donor type and conditioning FREE
S Chakrabarti, H Osman, K Collingham and D W Milligan
Bone Marrow Transplant 31: 379-386; doi:10.1038/sj.bmt.1703847
Chimerism
Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning FREE
D Valcárcel, R Martino, D Caballero, M V Mateos, J A Pérez-Simón, C Canals, F Fernández, J Bargay, E Muñiz-Díaz, M Gonzalez, J F San Miguel and J Sierra
Bone Marrow Transplant 31: 387-392; doi:10.1038/sj.bmt.1703846
Post-transplant Complications
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria FREE
A Maiolino, I Biasoli, J Lima, A C Portugal, W Pulcheri and M Nucci
Bone Marrow Transplant 31: 393-397; doi:10.1038/sj.bmt.1703855
Case Reports
Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect FREE
A M Marmont, F Gualandi, M T van Lint and A Bacigalupo
Bone Marrow Transplant 31: 399-402; doi:10.1038/sj.bmt.1703833
Successful umbilical cord blood stem cell transplantation for chronic granulomatous disease FREE
A Bhattacharya, M Slatter, A Curtis, C E Chapman, D Barge, A Jackson, T J Flood, M Abinun, A J Cant and A R Gennery
Bone Marrow Transplant 31: 403-405; doi:10.1038/sj.bmt.1703863
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for treatment of Dyskeratosis congenita FREE
T Güngör, S Corbacioglu, R Storb and R A Seger
Bone Marrow Transplant 31: 407-410; doi:10.1038/sj.bmt.1703844
Correspondence
Successful treatment of disseminated fusariosis FREE
C A Rodriguez, J Luján-Zilbermann, P Woodard, M Andreansky and E E Adderson
Bone Marrow Transplant 31: 411-412; doi:10.1038/sj.bmt.1703857
Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia FREE
A-M Tsimberidou, J Medina, M Earl, M Sierra, J E Shriki, C Bueso-Ramos, S Giralt, M Beran, F J Giles and G Garcia-Manero
Bone Marrow Transplant 31: 413-414; doi:10.1038/sj.bmt.1703853
